Targeting Integrins αvβ3 and αvβ5 for Bloking Tumor-Induced Angiogenesis
暂无分享,去创建一个
B. Neustadt | E. Maxwell | L. Armstrong | C. Kumar | M. Malkowski | Z. Yin | Ming Liu | J. Varner | B. Yaremko | T. Nechuta | Elizabeth M. Smith | H. Ling | Bo Yaremko | T. Nechuta
[1] N. Kleiman,et al. Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use? , 1999, Circulation.
[2] F. Mitjans,et al. Integrin αVβ3 Promotes M21 Melanoma Growth in Human Skin by Regulating Tumor Cell Survival , 1999 .
[3] R. Soldi,et al. Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor‐2 , 1999, The EMBO journal.
[4] C. Kumar,et al. Signaling by integrin receptors , 1998, Oncogene.
[5] E. Maxwell,et al. Biochemical Characterization of the Binding of Echistatin to Integrin αvβ3 Receptor , 1997 .
[6] Chandra L. Theesfeld,et al. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Becker,et al. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. , 1996, The Journal of clinical investigation.
[8] W. Stetler-Stevenson,et al. Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.
[9] D. Cheresh,et al. Review: The Integrin αvβ3: Angiogenesis and Apoptosis , 1995 .
[10] F. Sarkar,et al. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.
[11] S. Shattil. Function and Regulation of the β3 Integrins in Hemostasis and Vascular Biology , 1995, Thrombosis and Haemostasis.
[12] J. Nip,et al. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells. , 1995, The Journal of clinical investigation.
[13] D. Cheresh,et al. Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.
[14] John Calvin Reed,et al. Anchorage dependence, integrins, and apoptosis , 1994, Cell.
[15] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[16] J. Tschopp,et al. Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists. , 1994, Journal of medicinal chemistry.
[17] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[18] J. Folkman,et al. The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.
[19] M. Hendrix,et al. Role of the alpha v beta 3 integrin in human melanoma cell invasion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] V. Garsky,et al. Proton NMR assignments and secondary structure of the snake venom protein echistatin. , 1991, Biochemistry.
[21] D. Elder,et al. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. , 1990, Cancer research.
[22] S. Bodary,et al. The integrin beta 1 subunit associates with the vitronectin receptor alpha v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. , 1990, The Journal of biological chemistry.
[23] S. Bodary,et al. Expression of recombinant platelet glycoprotein IIbIIIa results in a functional fibrinogen-binding complex. , 1989, The Journal of biological chemistry.
[24] E Ruoslahti,et al. RGD and other recognition sequences for integrins. , 1996, Annual review of cell and developmental biology.